Aster Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-617
Closed -$4.32K 1307
2025
Q4
$4.32K Sell
617
-4,206
-87% -$32.9K ﹤0.01% 887
2025
Q3
$37.3K Buy
4,823
+2,425
+101% +$18.9K 0.02% 559
2025
Q2
$20.9K Sell
2,398
-28,983
-92% -$210K ﹤0.01% 700
2025
Q1
$300K Buy
31,381
+31,356
+125,424% +$317K 0.06% 392
2024
Q4
$227 Buy
+25
New +$241 ﹤0.01% 1058

Other funds holding TDOC

Aster Capital Management's TDOC Position: Q1 2026 in Review

Aster Capital Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 617 shares — an estimated $4.32K sold.

Aster Capital Management first reported a position in TDOC in Q4 2024 and held it in 5 quarters. The position peaked at $300K in Q1 2025. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Aster Capital Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 617 Teladoc Health shares in Q1 2026, an estimated $4.32K.
  • Aster Capital Management first reported a position in Teladoc Health in Q4 2024 and held it in 5 quarters.
  • Aster Capital Management's Teladoc Health position peaked at $300K in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.